| P/E (FY) | — | Sales (TTM) | $95.1M |
| Earnings (TTM) | -$60.4M | ROE | −30.83% |
| Net Margin | −59.97% | ROIC | −82.64% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
CeriBell is a medical technology company in the United States that develops the Ceribell System, a point-of-care EEG platform designed for acute care settings. Its offerings include disposable flexible headbands and headcaps, a pocket-sized rechargeable recorder that captures and wirelessly transmits EEG signals, the Clarity AI-powered seizure detection algorithm, and an EEG portal for real-time remote access to patient data. It was formerly Brain Stethoscope, Inc.
| Market Cap | $676.5M | Trading Days | 438 |
| 52W High | 24.33 |
| 52W Low | 10.85 |
| % Off High | −26.72% |
| YTD | −18.70% | 1Y | 19.18% |
| Since incept. (ann.) | −17.18% |
Product 76% · Subscription 24%
| Ann. Volatility (1Y) | 55.11% | Ann. Volatility (3Y) | 67.78% |
| Sharpe (1Y) | 0.61 | Sharpe (3Y) | 0.07 |
| Max Drawdown (1Y) | −30.52% | Max Drawdown (3Y) | −63.89% |
| Beta (3Y, vs SPY) | 0.86 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| CNMD | CONMED Corp | $1.36B | 29.3 |
| CV | CapsoVision, Inc | $330.8M | — |
| ELMD | Electromed, Inc. | $326.9M | 46.4 |
| BLFS | BIOLIFE SOLUTIONS INC | $1.56B | — |
| AXGN | Axogen, Inc. | $2.19B | — |
| TMDX | TransMedics Group, Inc. | $2.64B | 15.7 |
| ITGR | Integer Holdings Corp | $3.41B | 34.7 |
| STXS | Stereotaxis, Inc. | $125.1M | — |
| VANI | Vivani Medical, Inc. | $113.0M | — |
| LIVN | LivaNova PLC | $4.51B | — |
| OM | Outset Medical, Inc. | $87.5M | — |
| NRXS | Neuraxis, INC |
| $80.9M |
| — |
